|
Sales Training America Launches Exceptional Presentations Training for Bayer, Inc.Bayer, Inc. has again selected Sales Training America to deliver Exceptional Presentations training for one of their Engineering groups. Bayer has contracted with STA on previous occasions, and when the need for a presentations training workshop arose they were quick to return to the industry experts. STA’s proven course content and client-centered approach has made them Bayer’s trusted training partner for several years. Two Senior Level Sales Training America Instructors and
Exceptional Presentations Experts will deliver the workshop to Bayer
engineers. During this highly interactive training experience,
participants will gain experience using fundamental public speaking
techniques, such as the Four P’s of vocal quality (Projection, Pauses,
Pacing and Pitch), to keep their presentations lively and engaging. They
will also learn strategies for analyzing the audience and delivering a
presentation that will appeal to the interests of their listeners,
ensuring that they retain the audience’s attention and successfully
communicate their message. Attendees will also benefit from personal,
one-on-one coaching, receiving expert feedback on ten video recordings
of practice presentations delivered during the workshop. Bayer is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Their products and services are designed to benefit people and improve their quality of life. At the same time the company strives to create value through innovation, growth and high earning power. In the future, Bayer will focus on innovation and growth in the areas of health care, nutrition and high-tech materials. The mission statement, "We have set our course for the future," underscores Bayer’s willingness as an inventor company to help shape the future and their determination to come up with innovations that benefit humankind. Of special importance in this respect are new products emerging from Bayer’s active substance research, the consumer health business, the growth markets of Asia, and new areas such as biotechnology and nanotechnology. |
||||||
|
|||||||